Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer

BACKGROUND: Early-stage lung cancer represents a key focus of numerous multicenter clinical trials, but common exclusion criteria such as a prior cancer diagnosis may limit enrollment. We examined the prevalence and prognostic impact of a prior cancer diagnosis among patients with early-stage lung c...

Descripción completa

Detalles Bibliográficos
Autores principales: Pruitt, Sandi L, Laccetti, Andrew L, Xuan, Lei, Halm, Ethan A, Gerber, David E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355931/
https://www.ncbi.nlm.nih.gov/pubmed/28196065
http://dx.doi.org/10.1038/bjc.2017.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355931/
https://www.ncbi.nlm.nih.gov/pubmed/28196065
http://dx.doi.org/10.1038/bjc.2017.27

Ejemplares similares